{"id":62904,"date":"2026-04-08T04:02:24","date_gmt":"2026-04-08T02:02:24","guid":{"rendered":"https:\/\/pharma-trend.com\/en\/meiji-pharma-asia-commences-operations-in-singapore\/"},"modified":"2026-04-08T04:02:24","modified_gmt":"2026-04-08T02:02:24","slug":"meiji-pharma-asia-commences-operations-in-singapore","status":"publish","type":"post","link":"https:\/\/pharma-trend.com\/en\/meiji-pharma-asia-commences-operations-in-singapore\/","title":{"rendered":"Meiji Pharma Asia Commences Operations in Singapore"},"content":{"rendered":"
\n

TOKYO–(BUSINESS WIRE)–Meiji Seika Pharma Co., Ltd. (Headquarters: Tokyo, Japan, President and Representative Director: Toshiaki Nagasato) announced that its local subsidiary, Meiji Pharma Asia Pte. Ltd. (Headquarters: Singapore, Managing Director: Kensuke Hata) commenced operations in Singapore on April 1,2026. This subsidiary is intended to strengthen Meiji Seika Pharma\u2019s presence and expand its business in the ASEAN region through the commercialization, marketing and distribution of pharmaceuticals, including vaccines.<\/p>\n

<\/a>
<\/a><\/p>\n

\nMeiji Seika Pharma aims to become “a leading company in Asia in the field of infectious diseases” as part of the “Meiji Group 2026 Vision” targeting 2026. Leveraging nearly half a century of experience in manufacturing and marketing pharmaceuticals in Thailand and Indonesia, Meiji Seika Pharma will position Singapore as a hub for its business and commercial strategies across the ASEAN region, with the aim of further enhancing its influence and accelerating growth in the region.<\/p>\n

\nMeiji Pharma Asia focuses on commercializing, marketing and distributing pharmaceuticals including vaccines, in the fields of infectious diseases, hematologic cancers, and lifestyle-related diseases. Through Meiji Pharma Asia, Meiji Seika Pharma intends to reliably supply pharmaceuticals and contribute to the health and well-being of the people in the region.<\/p>\n

\nCompany Overview<\/b><\/p>\n

\n(1) Name: Meiji Pharma Asia Pte. Ltd.
\n
(2) Location: Singapore
\n
(3) Representative (Managing Director): Kensuke Hata
\n
(4) Incorporation Type: Private Limited Company
\n
(5) Business Description: Commercialization, marketing and distribution of pharmaceuticals including vaccines, etc.
\n
(6) Capital: 1.5 million Singapore Dollars
\n
(7) Date of Establishment: December 10, 2025
\n
(8) Date of Commencement of Operations: April 1, 2026
\n
(9) Shareholder Composition: Wholly owned subsidiary of Meiji Seika Pharma Co., Ltd.<\/p>\n

Contacts<\/b> <\/p>\n

\nFor further information, please contact:
\n
Kensuke Hata
\n
Meiji Pharma Asia Pte. Ltd.
\n
E-mail: mpa-contact@meiji.com<\/a><\/p>\n<\/div>\n","protected":false},"excerpt":{"rendered":"

TOKYO–(BUSINESS WIRE)–Meiji Seika Pharma Co., Ltd. (Headquarters: Tokyo, Japan, President and Representative Director: Toshiaki Nagasato) announced that its local subsidiary, Meiji Pharma Asia Pte. Ltd. (Headquarters: Singapore, Managing Director: Kensuke Hata) commenced operations in Singapore on April 1,2026. This subsidiary is intended to strengthen Meiji Seika Pharma\u2019s presence and expand its business in the ASEAN … [Read more…]<\/a><\/span><\/p>\n","protected":false},"author":4,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[13],"tags":[],"class_list":{"0":"entry","1":"post","2":"publish","3":"author-business","4":"post-62904","6":"format-standard","7":"category-industry"},"yoast_head":"\nMeiji Pharma Asia Commences Operations in Singapore - Pharma Trend<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/pharma-trend.com\/en\/meiji-pharma-asia-commences-operations-in-singapore\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Meiji Pharma Asia Commences Operations in Singapore - Pharma Trend\" \/>\n<meta property=\"og:description\" content=\"TOKYO–(BUSINESS WIRE)–Meiji Seika Pharma Co., Ltd. (Headquarters: Tokyo, Japan, President and Representative Director: Toshiaki Nagasato) announced that its local subsidiary, Meiji Pharma Asia Pte. Ltd. (Headquarters: Singapore, Managing Director: Kensuke Hata) commenced operations in Singapore on April 1,2026. This subsidiary is intended to strengthen Meiji Seika Pharma\u2019s presence and expand its business in the ASEAN ... [Read more...]\" \/>\n<meta property=\"og:url\" content=\"https:\/\/pharma-trend.com\/en\/meiji-pharma-asia-commences-operations-in-singapore\/\" \/>\n<meta property=\"og:site_name\" content=\"Pharma Trend\" \/>\n<meta property=\"article:published_time\" content=\"2026-04-08T02:02:24+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/mms.businesswire.com\/media\/20260407637578\/en\/774049\/22\/1_Meiji_BrandMark_300.jpg\" \/>\n<meta name=\"author\" content=\"Business Wire\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Business Wire\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"1 minute\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/meiji-pharma-asia-commences-operations-in-singapore\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/meiji-pharma-asia-commences-operations-in-singapore\\\/\"},\"author\":{\"name\":\"Business Wire\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/person\\\/02d41342c7a74fa7f0032bb35ef0bb24\"},\"headline\":\"Meiji Pharma Asia Commences Operations in Singapore\",\"datePublished\":\"2026-04-08T02:02:24+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/meiji-pharma-asia-commences-operations-in-singapore\\\/\"},\"wordCount\":270,\"publisher\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#organization\"},\"image\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/meiji-pharma-asia-commences-operations-in-singapore\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20260407637578\\\/en\\\/774049\\\/22\\\/1_Meiji_BrandMark_300.jpg\",\"articleSection\":[\"Industry\"],\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/meiji-pharma-asia-commences-operations-in-singapore\\\/\",\"url\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/meiji-pharma-asia-commences-operations-in-singapore\\\/\",\"name\":\"Meiji Pharma Asia Commences Operations in Singapore - Pharma Trend\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/meiji-pharma-asia-commences-operations-in-singapore\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/meiji-pharma-asia-commences-operations-in-singapore\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20260407637578\\\/en\\\/774049\\\/22\\\/1_Meiji_BrandMark_300.jpg\",\"datePublished\":\"2026-04-08T02:02:24+00:00\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/meiji-pharma-asia-commences-operations-in-singapore\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/pharma-trend.com\\\/en\\\/meiji-pharma-asia-commences-operations-in-singapore\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/meiji-pharma-asia-commences-operations-in-singapore\\\/#primaryimage\",\"url\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20260407637578\\\/en\\\/774049\\\/22\\\/1_Meiji_BrandMark_300.jpg\",\"contentUrl\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20260407637578\\\/en\\\/774049\\\/22\\\/1_Meiji_BrandMark_300.jpg\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/meiji-pharma-asia-commences-operations-in-singapore\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Startseite\",\"item\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Meiji Pharma Asia Commences Operations in Singapore\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#website\",\"url\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/\",\"name\":\"Pharma Trend\",\"description\":\"\",\"publisher\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Organization\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#organization\",\"name\":\"Pharma Trend\",\"url\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/logo\\\/image\\\/\",\"url\":\"\",\"contentUrl\":\"\",\"caption\":\"Pharma Trend\"},\"image\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/logo\\\/image\\\/\"}},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/person\\\/02d41342c7a74fa7f0032bb35ef0bb24\",\"name\":\"Business Wire\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Meiji Pharma Asia Commences Operations in Singapore - Pharma Trend","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/pharma-trend.com\/en\/meiji-pharma-asia-commences-operations-in-singapore\/","og_locale":"en_US","og_type":"article","og_title":"Meiji Pharma Asia Commences Operations in Singapore - Pharma Trend","og_description":"TOKYO–(BUSINESS WIRE)–Meiji Seika Pharma Co., Ltd. (Headquarters: Tokyo, Japan, President and Representative Director: Toshiaki Nagasato) announced that its local subsidiary, Meiji Pharma Asia Pte. Ltd. (Headquarters: Singapore, Managing Director: Kensuke Hata) commenced operations in Singapore on April 1,2026. This subsidiary is intended to strengthen Meiji Seika Pharma\u2019s presence and expand its business in the ASEAN ... [Read more...]","og_url":"https:\/\/pharma-trend.com\/en\/meiji-pharma-asia-commences-operations-in-singapore\/","og_site_name":"Pharma Trend","article_published_time":"2026-04-08T02:02:24+00:00","og_image":[{"url":"https:\/\/mms.businesswire.com\/media\/20260407637578\/en\/774049\/22\/1_Meiji_BrandMark_300.jpg","type":"","width":"","height":""}],"author":"Business Wire","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Business Wire","Est. reading time":"1 minute"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/pharma-trend.com\/en\/meiji-pharma-asia-commences-operations-in-singapore\/#article","isPartOf":{"@id":"https:\/\/pharma-trend.com\/en\/meiji-pharma-asia-commences-operations-in-singapore\/"},"author":{"name":"Business Wire","@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/person\/02d41342c7a74fa7f0032bb35ef0bb24"},"headline":"Meiji Pharma Asia Commences Operations in Singapore","datePublished":"2026-04-08T02:02:24+00:00","mainEntityOfPage":{"@id":"https:\/\/pharma-trend.com\/en\/meiji-pharma-asia-commences-operations-in-singapore\/"},"wordCount":270,"publisher":{"@id":"https:\/\/pharma-trend.com\/en\/#organization"},"image":{"@id":"https:\/\/pharma-trend.com\/en\/meiji-pharma-asia-commences-operations-in-singapore\/#primaryimage"},"thumbnailUrl":"https:\/\/mms.businesswire.com\/media\/20260407637578\/en\/774049\/22\/1_Meiji_BrandMark_300.jpg","articleSection":["Industry"],"inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/pharma-trend.com\/en\/meiji-pharma-asia-commences-operations-in-singapore\/","url":"https:\/\/pharma-trend.com\/en\/meiji-pharma-asia-commences-operations-in-singapore\/","name":"Meiji Pharma Asia Commences Operations in Singapore - Pharma Trend","isPartOf":{"@id":"https:\/\/pharma-trend.com\/en\/#website"},"primaryImageOfPage":{"@id":"https:\/\/pharma-trend.com\/en\/meiji-pharma-asia-commences-operations-in-singapore\/#primaryimage"},"image":{"@id":"https:\/\/pharma-trend.com\/en\/meiji-pharma-asia-commences-operations-in-singapore\/#primaryimage"},"thumbnailUrl":"https:\/\/mms.businesswire.com\/media\/20260407637578\/en\/774049\/22\/1_Meiji_BrandMark_300.jpg","datePublished":"2026-04-08T02:02:24+00:00","breadcrumb":{"@id":"https:\/\/pharma-trend.com\/en\/meiji-pharma-asia-commences-operations-in-singapore\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/pharma-trend.com\/en\/meiji-pharma-asia-commences-operations-in-singapore\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/pharma-trend.com\/en\/meiji-pharma-asia-commences-operations-in-singapore\/#primaryimage","url":"https:\/\/mms.businesswire.com\/media\/20260407637578\/en\/774049\/22\/1_Meiji_BrandMark_300.jpg","contentUrl":"https:\/\/mms.businesswire.com\/media\/20260407637578\/en\/774049\/22\/1_Meiji_BrandMark_300.jpg"},{"@type":"BreadcrumbList","@id":"https:\/\/pharma-trend.com\/en\/meiji-pharma-asia-commences-operations-in-singapore\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Startseite","item":"https:\/\/pharma-trend.com\/en\/"},{"@type":"ListItem","position":2,"name":"Meiji Pharma Asia Commences Operations in Singapore"}]},{"@type":"WebSite","@id":"https:\/\/pharma-trend.com\/en\/#website","url":"https:\/\/pharma-trend.com\/en\/","name":"Pharma Trend","description":"","publisher":{"@id":"https:\/\/pharma-trend.com\/en\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/pharma-trend.com\/en\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Organization","@id":"https:\/\/pharma-trend.com\/en\/#organization","name":"Pharma Trend","url":"https:\/\/pharma-trend.com\/en\/","logo":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/logo\/image\/","url":"","contentUrl":"","caption":"Pharma Trend"},"image":{"@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/logo\/image\/"}},{"@type":"Person","@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/person\/02d41342c7a74fa7f0032bb35ef0bb24","name":"Business Wire"}]}},"_links":{"self":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/posts\/62904","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/users\/4"}],"replies":[{"embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/comments?post=62904"}],"version-history":[{"count":0,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/posts\/62904\/revisions"}],"wp:attachment":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/media?parent=62904"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/categories?post=62904"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/tags?post=62904"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}